Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Partridge

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Medicinal Chemistry|November 14, 2024
Discovery and Optimization of First-in-Class Molecular Glue Degraders of the WIZ Transcription Factor for Fetal Hemoglobin Induction to Treat Sickle Cell DiseaseJohn Ryan Kerrigan, Noel M Thomsen, Artiom Cernijenko, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell HemoglobinBrian Metcalf, Chihyuan Chuang, Kobina Dufu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 1, 2025
A differentiated β-globin gene replacement strategy uses heterologous introns to restore physiological expressionKirby A Wallace, Trevor L Gerstenberg, Craig L Ennis, et al.
Nature Communications|March 24, 2024
Functional screening in human HSPCs identifies optimized protein-based enhancers of Homology Directed RepairJuan A Perez-Bermejo, Oghene Efagene, William M Matern, et al.
Science Advances|April 23, 2025
Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus M<sup>Pro</sup> inhibitors with potent in vivo efficacyTyler C Detomasi, Gilles Degotte, Sijie Huang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Medicinal Chemistry|November 14, 2024
Discovery and Optimization of First-in-Class Molecular Glue Degraders of the WIZ Transcription Factor for Fetal Hemoglobin Induction to Treat Sickle Cell DiseaseJohn Ryan Kerrigan, Noel M Thomsen, Artiom Cernijenko, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell HemoglobinBrian Metcalf, Chihyuan Chuang, Kobina Dufu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 1, 2025
A differentiated β-globin gene replacement strategy uses heterologous introns to restore physiological expressionKirby A Wallace, Trevor L Gerstenberg, Craig L Ennis, et al.
Nature Communications|March 24, 2024
Functional screening in human HSPCs identifies optimized protein-based enhancers of Homology Directed RepairJuan A Perez-Bermejo, Oghene Efagene, William M Matern, et al.
Science Advances|April 23, 2025
Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus M<sup>Pro</sup> inhibitors with potent in vivo efficacyTyler C Detomasi, Gilles Degotte, Sijie Huang, et al.
Pageof 2